Resolution of Fenfluramine-associated pulmonary arterial hypertension in Lennox-Gastaut syndrome: A case report and literature review

Fenfluramine is a medication originally approved for weight loss before being withdrawn for an association with the development of pulmonary arterial hypertension (PAH) and cardiac valvulopathy. Interest in fenfluramine at lower doses has re-emerged for treatment of drug-resistant epilepsy (DRE). He...

Full description

Bibliographic Details

Published in:	Epilepsy & Behavior Reports
Main Authors:	Rebecca Strafella, Richard Wang, Marissa Petchpradub, Ariel Sacknovitz, Patricia E. McGoldrick, Steven M. Wolf
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Subjects:	Drug-resistant epilepsy LGS Lennox-Gastaut Syndrome Fintepla
Online Access:	http://www.sciencedirect.com/science/article/pii/S258998642400087X